Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 797490, 7 pages
http://dx.doi.org/10.1155/2015/797490
Research Article

Type of Renal Replacement Therapy (Hemodialysis versus Peritoneal Dialysis) Does Not Affect Cytokine Gene Expression or Clinical Parameters of Renal Transplant Candidates

1Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wrocław, Poland
2Department of Vascular, General and Transplant Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wrocław, Poland
3Department of Histology and Embryology, Wroclaw Medical University, Chałubińskiego 6a, 50-368 Wrocław, Poland

Received 9 January 2015; Revised 24 May 2015; Accepted 23 June 2015

Academic Editor: Detlef H. Krieter

Copyright © 2015 Dorota Kamińska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Dinits-Pensy, G. N. Forrest, A. S. Cross, and M. K. Hise, “The use of vaccines in adult patients with renal disease,” American Journal of Kidney Diseases, vol. 46, no. 6, pp. 997–1011, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. S. Lewis and D. J. Sexton, “Metastatic complications of bloodstream infections in hemodialysis patients,” Seminars in Dialysis, vol. 26, no. 1, pp. 47–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Alexiewicz, M. Klinger, T. O. Pitts, Z. Gaciong, M. Linker-Israeli, and S. G. Massry, “Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure,” Journal of the American Society of Nephrology, vol. 1, no. 3, pp. 236–244, 1990. View at Google Scholar · View at Scopus
  4. J. M. Alexiewicz, Z. Gaciong, M. Klinger, M. Linker-Israeli, T. O. Pitts, and S. G. Massry, “Evidence of impaired T cell function in hemodialysis patients: potential role for secondary hyperparathyroidism,” The American Journal of Nephrology, vol. 10, no. 6, pp. 495–501, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Shurtz-Swirski, T. Shkolnik, and S. M. Shasha, “Parathyroid hormone and the cellular immune system,” Nephron, vol. 70, no. 1, pp. 21–24, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Zager, A. C. M. Johnson, and S. Lund, “Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury,” The American Journal of Physiology—Renal Physiology, vol. 297, no. 4, pp. F961–F970, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Chonchol, “Neutrophil dysfunction and infection risk in end-stage renal disease,” Seminars in Dialysis, vol. 19, no. 4, pp. 291–296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Porazko, J. Kuźniar, M. Kusztal et al., “IL-18 is involved in vascular injury in end-stage renal disease patients,” Nephrology Dialysis Transplantation, vol. 24, no. 2, pp. 589–596, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Stompór, M. Pasowicz, W. Sułowicz et al., “An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis,” American Journal of Kidney Diseases, vol. 41, no. 1, pp. 203–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. T. K. Hendrikx, E. A. F. J. van Gurp, W. M. Mol et al., “End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells,” Nephrology Dialysis Transplantation, vol. 24, no. 6, pp. 1969–1978, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. K. W. Kim, B. H. Chung, E. J. Jeon et al., “B cell-associated immune profiles in patients with end-stage renal disease (ESRD),” Experimental & Molecular Medicine, vol. 44, no. 8, pp. 465–472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Libetta, T. Rampino, and A. Dal Canton, “Polarization of t-helper lymphocytes toward the Th2 phenotype in uremic patients,” American Journal of Kidney Diseases, vol. 38, no. 2, pp. 286–295, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Libetta, P. Esposito, V. Sepe et al., “Effects of different peritoneal dialysis fluids on the Th1/Th2 balance,” European Cytokine Network, vol. 22, no. 1, pp. 24–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Borazan, H. Ustün, Y. Ustundag et al., “The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels,” Mediators of Inflammation, vol. 13, no. 3, pp. 201–204, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. N. D. Vaziri, M. V. Pahl, A. Crum, and K. Norris, “Effect of uremia on structure and function of immune system,” Journal of Renal Nutrition, vol. 22, no. 1, pp. 149–156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kato, M. Chmielewski, H. Honda et al., “Aspects of immune dysfunction in end-stage renal disease,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 5, pp. 1526–1533, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Libetta, V. Sepe, and A. Dal Canton, “Bio-incompatibility and Th2 polarization during regular dialysis treatment,” International Reviews of Immunology, vol. 29, no. 6, pp. 608–625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. B. H. Chung, K. W. Kim, I. O. Sun et al., “Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients,” Immunology Letters, vol. 141, no. 2, pp. 181–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Zhang, G. Hua, X. Zhang, R. Tong, X. Du, and Z. Li, “Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events,” Nephrology, vol. 15, no. 1, pp. 33–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Pruijm, B. Ponte, P. Vollenweider et al., “Not all inflammatory markers are linked to kidney function: results from a population-based study,” The American Journal of Nephrology, vol. 35, no. 3, pp. 288–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Stenvinkel, M. Ketteler, R. J. Johnson et al., “IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly,” Kidney International, vol. 67, no. 4, pp. 1216–1233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. N. R. Powe, B. Jaar, S. L. Furth, J. Hermann, and W. Briggs, “Septicemia in dialysis patients: incidence, risk factors, and prognosis,” Kidney International, vol. 55, no. 3, pp. 1081–1090, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Saini, A.-S. Nasser, and C. E. H. Stewart, “Waste management-cytokines, growth factors and cachexia,” Cytokine and Growth Factor Reviews, vol. 17, no. 6, pp. 475–486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Gupta, N. Mitra, P. A. Kanetsky et al., “Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 12, pp. 1938–1946, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kalantar-Zadeh, J. D. Kopple, G. Block, and M. H. Humphreys, “A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients,” The American Journal of Kidney Diseases, vol. 38, no. 6, pp. 1251–1263, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Beberashvili, A. Azar, I. Sinuani et al., “Objective Score of Nutrition on Dialysis (OSND) as an alternative for the malnutrition-inflammation score in assessment of nutritional risk of haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 25, no. 8, pp. 2662–2671, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Girndt, C. Ulrich, H. Kaul, U. Sester, M. Sester, and H. Köhler, “Uremia-associated immune defect: the IL-10-CRP axis,” Kidney International Supplement, vol. 63, no. 84, pp. S76–S79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Stankovic-Popovic, V. Nesic, D. Popovic et al., “Effects of conventional versus biocompatible peritoneal dialysis solutions on peritoneal and systemic inflammation, malnutrition and atherosclerosis in CAPD patients,” Clinical Nephrology, vol. 76, no. 4, pp. 314–322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-H. Hwang, M.-J. Son, J. Yang et al., “Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 29, no. 1, pp. 81–88, 2009. View at Google Scholar · View at Scopus
  30. E. Dounousi, E. Koliousi, A. Papagianni et al., “Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease,” The American Journal of Nephrology, vol. 36, no. 6, pp. 531–536, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Majewska, Z. Baj, Z. Sulowska, J. Rysz, and M. Luciak, “Effects of uraemia and haemodialysis on neutrophil apoptosis and expression of apoptosis-related proteins,” Nephrology Dialysis Transplantation, vol. 18, no. 12, pp. 2582–2588, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Rau, A. Habicht, T. Kauke et al., “Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys!,” European Journal of Clinical Investigation, vol. 43, no. 8, pp. 816–820, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. G. M. Virzì, A. Clementi, M. de Cal, D. N. Cruz, and C. Ronco, “Genomics and biological activity of neutrophil gelatinase-associated lipocalin in several clinical settings,” Blood Purification, vol. 35, no. 1–3, pp. 139–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. N. E. Magnusson, M. Hornum, K. A. Jorgensen et al., “Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation,” BMC Nephrology, vol. 13, article 8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Wang, K. S. L. Lam, E. W. Kraegen et al., “Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans,” Clinical Chemistry, vol. 53, no. 1, pp. 34–41, 2007. View at Publisher · View at Google Scholar · View at Scopus